期刊文献+

TCF21对喉癌Hep-2细胞生物学行为的影响 被引量:3

Effect of TCF21 on cellular biological characteristics in laryngeal carcinoma Hep-2 cell
下载PDF
导出
摘要 目的:探讨转录因子21(transcription factor 21,TCF21)对喉癌细胞株Hep-2生物学特性的影响及其相关的作用机制。方法:利用慢病毒转染技术外源性过表达喉癌Hep-2细胞中的TCF21,然后分别采用细胞增殖检测(Cell Counting Kit-8,CCK-8)法和流式细胞术检测细胞增殖及凋亡能力的变化;Western印迹检测周期及凋亡相关蛋白的表达。结果:在Hep-2细胞中过表达TCF21后,细胞的增殖能力显著降低,周期进程缓慢,而细胞凋亡显著增加;Transwell细胞迁移实验显示过表达TCF21可抑制Hep-2细胞迁移。Western印迹实验结果显示过表达TCF21后,cyclin D1,CDK4,CDK6,p-R b及b c l-2的蛋白表达水平显著下降;P 2 1和Ba x及c l eaved-c a s pa s e-3的蛋白表达水平显著升高。结论:人喉癌细胞株Hep-2中,过表达TCF21可通过调控周期及凋亡相关因子的表达,发挥增殖抑制及凋亡促进作用,提示TCF21可作为诊断和靶向治疗喉癌的潜在作用位点。 Objective: To investigate the effect and mechanism of transcription factor 21 (TCF21) on the cellular biological characteristics in laryngeal carcinoma cell line Hep-2. Methods: Lentiviral transfection was used to up-regulated TCF21 expression in Hep-2 cells, and then cell proliferation and apoptosis were detected with Cell Counting Kit-8 (CCK-8) assay and flow cytometry assay, respectively. The expression of cell cycle- and apoptosis-related molecules at protein level was measured by Western blot. Results: Over-expression of TCF21 suppressed cell proliferation and cell cycle, while promoted cell apoptosis in Hep-2 cell (P〈0.05). Western blot showed that the expression of cyclinD1, CDK4, CDK6, p-Rb and Bcl-2 at protein level decreased significantly after up-regulation of TCF21, with an increased expression of P21, Bax and cleaved-caspase-3 (P〈0.05). Conclusion: In Hep-2 cells, over-expression of TCF21 could suppress cell proliferation and cell cycle, while promote cell apoptosis via regulating the expression of cell cycle- and apoptosis-related molecules, suggesting that TCF21 may be a potential new target for diagnosis and targeted therapy of laryngeal carcinoma.
作者 杨庆军
出处 《临床与病理杂志》 2017年第8期1576-1582,共7页 Journal of Clinical and Pathological Research
关键词 转录因子21 喉癌 增殖 凋亡 transcription factor 21 laryngeal carcinoma proliferation apoptosis
  • 相关文献

参考文献1

二级参考文献25

  • 1Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Ciin, 2013, 63(1): 11-30.
  • 2Molina J, Yang P, Cassivi S et al. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc, 2008, 83(5): 584-594.
  • 3Mulshine J, Sullivan D. Clinical practice. Lung cancer screening. N Engl J Med, 2005, 352(26): 2714-2720.
  • 4Prager GW, Poettler M, Unseld M, et al. Angiogenesis in cancer: anti- VEGF escape mechanisms. Transl Lung Cancer Res, 2011, i (1): 14-25.
  • 5Gu X, Ma C, Yuan D, et al. Circulating soluble intercellular adhesion molecule-1 in lung cancer: a systematic review. Transl Lung Cancer Res, 2011, 1(1): 36-44.
  • 6Yang L, Li Y, Ling X, et al. A common genetic variant (97906C>A) ofDAB21P/AIPI is associated with an increased risk and early onset of lung cancer in Chinese males. PLoS One, 2011j 6(I0): e26944.
  • 7Yoo N Park S, Lee S. Mutational analysis oftumour suppressor gene NF2 in common solid cancers and acute leukaemias. Pathology, 2012 441: 29-32.
  • 8Ma C, Wei S, Song Y. T790M and acquired resistance ofEGFR TKI: a literature review of clinical reports. J "Ihorac Dis, 2011, 3(1): 10-18.
  • 9Ye YW, Jiang ZM, Li WH, et al. Down-regulation of TCF21 is associated with poor survival in clear cell renal cell carcinoma. Neoplasma, 2012, $9(6): 599-605.
  • 10Richards KL, Zhang B, Sun M, et al. Methylation of the candidate biomarker TCF21 is very frequent across a spectrum of early-stage nonsmall cell lung cancers. Cancer, 2011, 117(3): 606-617.

共引文献14

同被引文献26

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部